Extended application of subtraction arterial phase imaging in LI-RADS version 2018: a strategy to improve the diagnostic performance for hepatocellular carcinoma on gadoxetate disodium–enhanced MRI

[1] An C(2016)Liver imaging reporting and data system (LI-RADS) version 2014: understanding and application of the diagnostic algorithm Clin Mol Hepatol 22 296-307

[2] Rakhmonova G(2019)Comparison of international guidelines for noninvasive diagnosis of hepatocellular carcinoma: 2018 update Clin Mol Hepatol 25 245-263

[3] Choi JY(2018)Prospective Intraindividual comparison of magnetic resonance imaging with Gadoxetic acid and extracellular contrast for diagnosis of hepatocellular carcinomas using the liver imaging reporting and data system Hepatology 68 2254-2266

[4] Kim MJ(2019)Imaging features of hepatocellular carcinoma: quantitative and qualitative comparison between MRI-Enhanced with Gd-EOB-DTPA and Gd-DTPA Invest Radiol 54 494-499

[5] Kim TH(2005)Dynamic subtraction magnetic resonance imaging of cirrhotic liver: assessment of high signal intensity lesions on nonenhanced T1-weighted images J Comput Assist Tomogr 29 51-58

[6] Kim SY(2008)The role of dynamic subtraction MRI in detection of hepatocellular carcinoma Diagn Interv Radiol 14 200-204

[7] Tang A(2013)Added value of subtraction imaging in detecting arterial enhancement in small (<3 cm) hepatic nodules on dynamic contrast-enhanced MRI in patients at high risk of hepatocellular carcinoma Eur Radiol 23 924-930

[8] Lee JM(2017)Subtraction images of Gadoxetic acid-enhanced MRI: effect on the diagnostic performance for focal hepatic lesions in patients at risk for Hepatocellular carcinoma AJR Am J Roentgenol 209 584-591

[9] Min JH(2019)Arterial subtraction images of gadoxetate-enhanced MRI improve diagnosis of early-stage hepatocellular carcinoma J Hepatol 71 534-542

[10] Kim JM(2020)Retrospective comparison of EASL 2018 and LI-RADS 2018 for the noninvasive diagnosis of hepatocellular carcinoma using magnetic resonance imaging Hepatol Int 14 70-79

[1] An C(2016)Liver imaging reporting and data system (LI-RADS) version 2014: understanding and application of the diagnostic algorithm Clin Mol Hepatol 22 296-307

[2] Rakhmonova G(2019)Comparison of international guidelines for noninvasive diagnosis of hepatocellular carcinoma: 2018 update Clin Mol Hepatol 25 245-263

[3] Choi JY(2018)Prospective Intraindividual comparison of magnetic resonance imaging with Gadoxetic acid and extracellular contrast for diagnosis of hepatocellular carcinomas using the liver imaging reporting and data system Hepatology 68 2254-2266

[4] Kim MJ(2019)Imaging features of hepatocellular carcinoma: quantitative and qualitative comparison between MRI-Enhanced with Gd-EOB-DTPA and Gd-DTPA Invest Radiol 54 494-499

[5] Kim TH(2005)Dynamic subtraction magnetic resonance imaging of cirrhotic liver: assessment of high signal intensity lesions on nonenhanced T1-weighted images J Comput Assist Tomogr 29 51-58

[6] Kim SY(2008)The role of dynamic subtraction MRI in detection of hepatocellular carcinoma Diagn Interv Radiol 14 200-204

[7] Tang A(2013)Added value of subtraction imaging in detecting arterial enhancement in small (<3 cm) hepatic nodules on dynamic contrast-enhanced MRI in patients at high risk of hepatocellular carcinoma Eur Radiol 23 924-930

[8] Lee JM(2017)Subtraction images of Gadoxetic acid-enhanced MRI: effect on the diagnostic performance for focal hepatic lesions in patients at risk for Hepatocellular carcinoma AJR Am J Roentgenol 209 584-591

[9] Min JH(2019)Arterial subtraction images of gadoxetate-enhanced MRI improve diagnosis of early-stage hepatocellular carcinoma J Hepatol 71 534-542

[10] Kim JM(2020)Retrospective comparison of EASL 2018 and LI-RADS 2018 for the noninvasive diagnosis of hepatocellular carcinoma using magnetic resonance imaging Hepatol Int 14 70-79